The Transitions Project: Efficacy Trial

Study summary

The aim of this study is to evaluate the efficacy of a brief psychoeducational intervention to improve quality of life in patients with lung cancer who are transitioning from active treatment to surveillance.

Ask AI to explain this study

Start here

Key things to know

Main goalSupportive Care

This describes the study’s primary purpose.

What is being studiedFive Psycho-educational Session(s) and One Psycho-educational Session(s)

The study team can explain what participation involves.

Who it may be forLung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Mar 30, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Active Not Recruiting

The study is underway but is not accepting new participants.

What kind of study?Not applicable

Interventional

Where is it offered?2 U.S. locations

Locations may change over time.

Who runs it?Massachusetts General Hospital

Study sponsor

Study overview

What this study is about

Purpose: Supportive Care
Study type: Interventional
Phase: Not applicable
Sponsor: Massachusetts General Hospital
Interventions being studied: Behavioral: Five Psycho-educational Session(s); Behavioral: One Psycho-educational Session(s)

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach

Supportive or behavioral care→

Study topics

Survivorship and quality of life→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Age 21 or older
Able to read and respond in English
Diagnosis of non-small cell lung cancer or small cell lung cancer
Documented curative treatment plan including systemic therapy +/- radiation and +/- surgery
Completed cancer treatment within past 3 weeks
If final treatment is systemic therapy +/- radiation: within 3 weeks after cancer care team determination that treatment is complete
If final treatment is surgery: within 3 weeks after hospital discharge following surgery

Reasons someone may not be able to joinExclusion criteria

Comorbid health condition that would interfere with study participation
Current participation in cognitive behavioral therapy treatment

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Massachusetts General Hospital Cancer CenterBoston, Massachusetts
Dana-Farber Cancer InstituteBoston, Massachusetts

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Mar 30, 2026. Always confirm current availability with the study team.

View original record ↗